Sun Pharmaceutical Industries Ltd vs Zenlabs Ethica Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1807 as of 12 Jun 15:30 . The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 49.4 on March 2021 to 38.1 on March 2025 . This represents a CAGR of -5.06% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 143384 crore on March 2021 to ₹ 416392 crore on March 2025 . This represents a CAGR of 23.77% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 15070 crore as compare to the Dec '25 revenue of ₹ 16099 crore. This represent the decline of -6.39% The revenue of Zenlabs Ethica Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 4412 crore as compare to the Dec '25 ebitda of ₹ 5037 crore. This represent the decline of -12.41% The ebitda of Zenlabs Ethica Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2871 crore to ₹ 2723 crore over 8 quarters. This represents a CAGR of -2.60% The net profit of Zenlabs Ethica Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 213.61 % on March 2021 to 89.64 % on March 2025 . This represents a CAGR of -15.94% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993.
With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17. The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc.
The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India. In 2023, the Company ventured into diversified segments like Neurology and Cytrics.

FAQs for the comparison of Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Sun Pharmaceutical Industries Ltd or Zenlabs Ethica Ltd?

Market cap of Sun Pharmaceutical Industries Ltd is 433,619 Cr while Market cap of Zenlabs Ethica Ltd is 23 Cr

What are the key factors driving the stock performance of Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd?

The stock performance of Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd?

As of June 14, 2026, the Sun Pharmaceutical Industries Ltd stock price is INR ₹1807.25. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹35.7.

How do dividend payouts of Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Sun Pharmaceutical Industries Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.